Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 1Acute Kidney Injury 1

Interventions

Nivolumab 38pembrolizumab 30cabozantinib 27Specimen Handling 25Magnetic Resonance Spectroscopy 22Ipilimumab 20Axitinib 15lenvatinib 14belzutifan 13CTLA-4 Antigen 10Sunitinib 9Biopsy 9Radiosurgery 8atezolizumab 7Immunoglobulin G 5fludarabine 4avelumab 4aldesleukin 4Disulfides 4Cyclophosphamide 4zimberelimab 3toripalimab 3tivozanib 3pazopanib 3palbociclib 3durvalumab 3cemiplimab 3X-Rays 3Surveys and Questionnaires 3Nephrectomy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Renal Cell × Ischemic Preconditioning × 90 days × Clear all
NCT07497958 2026-03-27

Ischemic Preconditioning Reduces the Severity of Acute Kidney Injury After Partial Nephrectomy

Sun Yat-sen University

Phase NA Not yet recruiting
174 enrolled
Genitourinary

Carcinoma, Renal Cell, Acute Kidney Injury

Data powered by HemOnc (CC BY 4.0) Colophon âš¡